{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,2,10]],"date-time":"2024-02-10T00:33:02Z","timestamp":1707525182448},"reference-count":17,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,8,16]]},"DOI":"10.7759\/cureus.43588","type":"journal-article","created":{"date-parts":[[2023,8,16]],"date-time":"2023-08-16T17:34:55Z","timestamp":1692207295000},"source":"Crossref","is-referenced-by-count":0,"title":["Diagnostic Usefulness of Antibodies Against M-type Phospholipase A2 Receptor (aPLA2R) in Primary Membranous Nephropathy in the Mexican Population"],"prefix":"10.7759","author":[{"given":"Juan Daniel","family":"Diaz Garcia","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.12860\/JNP.2013.38","article-title":"Anti-phospholipase A2 receptor antibody in idiopathic membranous nephropathy: a report from Iranian population","volume":"2","author":"Ardalan M","year":"2013","unstructured":"Ardalan M, Ghafari A, Hamzavi F, Nasri H, Baradaran B, Majidi J, Nikbin B. Anti-phospholipase A2 receptor antibody in idiopathic membranous nephropathy: a report from Iranian population. J Nephropathol. 2013, 2:241-8. 10.12860\/JNP.2013.38","journal-title":"J Nephropathol"},{"key":"ref2","article-title":"Natural history, clinical course and morphological evolution of membranous nephropathy","volume":"7 Suppl 1","author":"E. Honkanen","year":"1992","unstructured":"E. Honkanen, T. Tornroth, C Gronhagen-Riska. Natural history, clinical course and morphological evolution of membranous nephropathy. Nephrol Dial Transplant. 1992, 7 Suppl 1:35-41.","journal-title":"Nephrol Dial Transplant"},{"key":"ref3","article-title":"Histopathological atlas of renal diseases: membranous glomerulonephritis","volume":"17","author":"F Ferrario","year":"2004","unstructured":"F Ferrario, M.P. Rastaldi. Histopathological atlas of renal diseases: membranous glomerulonephritis. J Nephrol. 2004, 17:635-6.","journal-title":"J Nephrol"},{"key":"ref4","article-title":"Nephrotic glomerulonephritis","volume":"33","author":"Jones DB","year":"1957","unstructured":"Jones DB. Nephrotic glomerulonephritis. Am J Pathol. 1957, 33:313-29.","journal-title":"Am J Pathol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0810457","article-title":"M-type phospholipase A2 receptor as target antigen in idiopathic membranous nephropathy","volume":"361","author":"Beck LH Jr","year":"2009","unstructured":"Beck LH Jr, Bonegio RG, Lambeau G, et al.. M-type phospholipase A2 receptor as target antigen in idiopathic membranous nephropathy. N Engl J Med. 2009, 361:11-21. 10.1056\/NEJMoa0810457","journal-title":"N Engl J Med"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2010111125","article-title":"Rituximab-induced depletion of anti-PLA2R autoantibodies predicts response in membranous nephropathy","volume":"22","author":"Beck LH Jr","year":"2011","unstructured":"Beck LH Jr, Fervenza FC, Beck DM, et al.. Rituximab-induced depletion of anti-PLA2R autoantibodies predicts response in membranous nephropathy. J Am Soc Nephrol. 2011, 22:1543-50. 10.1681\/ASN.2010111125","journal-title":"J Am Soc Nephrol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1038\/ki.2012.486","article-title":"Anti-PLA2R antibodies measured by ELISA predict long-term outcome in a prevalent population of patients with idiopathic membranous nephropathy","volume":"83","author":"Kanigicherla D","year":"2013","unstructured":"Kanigicherla D, Gummadova J, McKenzie EA, et al.. Anti-PLA2R antibodies measured by ELISA predict long-term outcome in a prevalent population of patients with idiopathic membranous nephropathy. Kidney Int. 2013, 83:940-8. 10.1038\/ki.2012.486","journal-title":"Kidney Int"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2011060610","article-title":"Circulating anti-PLA2R autoantibodies to monitor immunological activity in membranous nephropathy","volume":"22","author":"Cravedi P","year":"2011","unstructured":"Cravedi P, Ruggenenti P, Remuzzi G. Circulating anti-PLA2R autoantibodies to monitor immunological activity in membranous nephropathy. J Am Soc Nephrol. 2011, 22:1400-2. 10.1681\/ASN.2011060610","journal-title":"J Am Soc Nephrol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2010090967","article-title":"Anti-phospholipase A2 receptor antibody in membranous nephropathy","volume":"22","author":"Qin W","year":"2011","unstructured":"Qin W, Beck LH Jr, Zeng C, et al.. Anti-phospholipase A2 receptor antibody in membranous nephropathy. J Am Soc Nephrol. 2011, 22:1137-43. 10.1681\/ASN.2010090967","journal-title":"J Am Soc Nephrol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0062151","article-title":"Autoantibodies against phospholipase A2 receptor in Korean patients with membranous nephropathy","volume":"8","author":"Oh YJ","year":"2013","unstructured":"Oh YJ, Yang SH, Kim DK, Kang SW, Kim YS. Autoantibodies against phospholipase A2 receptor in Korean patients with membranous nephropathy. PLoS One. 2013, 8:e62151. 10.1371\/journal.pone.0062151","journal-title":"PLoS One"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfr247","article-title":"An immunofluorescence test for phospholipase-A\u2082-receptor antibodies and its clinical usefulness in patients with membranous glomerulonephritis","volume":"26","author":"Hoxha E","year":"2011","unstructured":"Hoxha E, Harendza S, Zahner G, et al.. An immunofluorescence test for phospholipase-A\u2082-receptor antibodies and its clinical usefulness in patients with membranous glomerulonephritis. Nephrol Dial Transplant. 2011, 26:2526-32. 10.1093\/ndt\/gfr247","journal-title":"Nephrol Dial Transplant"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2013040430","article-title":"Phospholipase A2 receptor autoantibodies and clinical outcome in patients with primary membranous nephropathy","volume":"25","author":"Hoxha E","year":"2014","unstructured":"Hoxha E, Thiele I, Zahner G, Panzer U, Harendza S, Stahl RA. Phospholipase A2 receptor autoantibodies and clinical outcome in patients with primary membranous nephropathy. J Am Soc Nephrol. 2014, 25:1357-66. 10.1681\/ASN.2013040430","journal-title":"J Am Soc Nephrol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1309\/AJCP8QMOY5GLRSFP","article-title":"Evaluation of anti-PLA2R1 as measured by a novel ELISA in patients with idiopathic membranous nephropathy: a cohort study","volume":"142","author":"Timmermans SA","year":"2014","unstructured":"Timmermans SA, Damoiseaux JG, Heerings-Rewinkel PT, et al.. Evaluation of anti-PLA2R1 as measured by a novel ELISA in patients with idiopathic membranous nephropathy: a cohort study. Am J Clin Pathol. 2014, 142:29-34. 10.1309\/AJCP8QMOY5GLRSFP","journal-title":"Am J Clin Pathol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.2215\/CJN.05880614","article-title":"Antiphospholipase A2 receptor autoantibody guided diagnosis and treatment of membranous nephropathy: a new personalized medical approach","volume":"9","author":"Glassock RJ","year":"2014","unstructured":"Glassock RJ. Antiphospholipase A2 receptor autoantibody guided diagnosis and treatment of membranous nephropathy: a new personalized medical approach. Clin J Am Soc Nephrol. 2014, 9:1341-3. 10.2215\/CJN.05880614","journal-title":"Clin J Am Soc Nephrol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1038\/ki.2012.209","article-title":"Enhanced expression of the M-type phospholipase A2 receptor in glomeruli correlates with serum receptor antibodies in primary membranous nephropathy","volume":"82","author":"Hoxha E","year":"2012","unstructured":"Hoxha E, Knei\u00dfler U, Stege G, et al.. Enhanced expression of the M-type phospholipase A2 receptor in glomeruli correlates with serum receptor antibodies in primary membranous nephropathy. Kidney Int. 2012, 82:797-804. 10.1038\/ki.2012.209","journal-title":"Kidney Int"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1038\/modpathol.2012.207","article-title":"Determination of primary versus secondary membranous glomerulopathy utilizing phospholipase A2 receptor staining in renal biopsies","volume":"26","author":"Larsen CP","year":"2013","unstructured":"Larsen CP, Messias NC, Silva FG, Messias E, Walker PD. Determination of primary versus secondary membranous glomerulopathy utilizing phospholipase A2 receptor staining in renal biopsies. Mod Pathol. 2013, 26:709-15. 10.1038\/modpathol.2012.207","journal-title":"Mod Pathol"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1148\/radiology.143.1.7063747","article-title":"The meaning and use of the area under a receiver operating characteristic (ROC) curve","volume":"143","author":"Hanley JA","year":"1982","unstructured":"Hanley JA, McNeil BJ. The meaning and use of the area under a receiver operating characteristic (ROC) curve. Radiology. 1982, 143:29-36. 10.1148\/radiology.143.1.7063747","journal-title":"Radiology"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/179208-diagnostic-usefulness-of-antibodies-against-m-type-phospholipase-a2-receptor-apla2r-in-primary-membranous-nephropathy-in-the-mexican-population","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T20:04:19Z","timestamp":1707509059000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/179208-diagnostic-usefulness-of-antibodies-against-m-type-phospholipase-a2-receptor-apla2r-in-primary-membranous-nephropathy-in-the-mexican-population"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,16]]},"references-count":17,"URL":"https:\/\/doi.org\/10.7759\/cureus.43588","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2023,8,16]]}}}